Volume 7

1. Abstract 1.1. Aim: COVID-19 pandemia has a significant negative influence on liver transplantation. The transplantation centers has used different managment protocols to overcome this public health concern. Data about COVID-19 in liver transplant recipients bases on limited availability of studies. We reported herein our institutional experience to contribute collecting data to achieve more precise …

Outcomes of COVID-19 in Liver Transplant Recipients: A Single Center Experience Read More »

1. Abstract 1.1. Aims: Percutaneous transhepatic biliary stenting (PTBS) can be associated with adverse events (AEs) of different severities. AEs might be assessed by a standardized AE severity grading system. The aim of this study was to compare the severity of adverse events in the 30-day interval after PTBS as a one- or two-stage procedure …

Adverse Event Severity Grading System Applied to Percutaneous Transhepatic Biliary Metal Stenting as A One- or Two-Stage Procedure in Patients with Unresectable Malignant Extrahepatic Bile Duct Obstruction Read More »

1. Abstract 1.1. Objective: To study the clinical, endoscopic and pathological features of Focal Nodular Hyperplasia (FNH) and hepatocellular carcinoma (HCC) in order to provide basis for differential diagnosis of FNH and HCC. DOI:http://dx.doi.org/10.47829/JJGH.2021.7104

1. Abstract 1.1. Background: Chronic kidney disease is one of the most significant complications after liver transplant. DOI:http://dx.doi.org/10.47829/JJGH.2021.7103